Astrazeneca Share Discussion Threads

[zho] 12/12/2020 16:54

AstraZeneca to buy Alexion in $39bn immunology deal

Anglo-Swedish drugmaker AstraZeneca has agreed to buy US biotechnology group Alexion in a $39bn deal, marking the biggest agreement struck by a pharmaceutical company since the start of the Covid-19 pandemic.

[donald t] 12/12/2020 13:31

AZN to buy Alexion shares for $39 billion

[philanderer] 12/12/2020 00:50

Alphorn , many thanks.

[freddie ferret] 11/12/2020 19:06

'Tis all over the interweb this teaming up with the Ruskies.

[alphorn] 11/12/2020 11:49

philanderer - that is why a potential combo will provide protection against a greater number of variations. (Don't quote me but I understand that the flu vaccine covers up to 5 variations now).

[montyhedge] 11/12/2020 11:41

Combining with Russian jab no thank you. US will want more data from Astra I would imagine before they approve.

[hjs] 11/12/2020 11:34

Personally, I do not like this trial combining 2 different vaccines. Astra should continue their efforts on their own. They have a good vaccine (traditional). In my opinion, the dosage mix up has caused the main issue and FDA has raised concerns. FDA assessment of Astra vaccine will be biased as we all know. They want their US vaccine to succeed first before anyone else. Boris should give full support for UK vaccine to succeed. I have full faith in Astra vaccine.

[philanderer] 11/12/2020 11:34

Alphorn, interesting development.

The big worry as always with a virus is that it will mutate.

[alphorn] 11/12/2020 11:14

Fascinating - AstraZeneca to trial combining its vaccine with Russian jab.

IMO as previously posted it will be a 'combo' that becomes the vaccine of choice in time.

[gregb] 10/12/2020 21:24

That's right, Astra's own jab AZ7442 has only just gone into phase 3 so will have to wait on the data :-)

[bountyhunter] 10/12/2020 19:24

Oxford vaccine ‘could be approved in dosage that makes it 90% effective’
Approval of the ‘home-grown’ jab could come before Christmas

"The Oxford vaccine could be given to Britons in the “half-dose, full dose” format that makes it 90 per cent effective, its lead scientist has said.

Professor Sarah Gilbert said it was possible that the MHRA, the UK’s medicines regulator, could approve the roll-out of the vaccine in the dosage that proved most effective in a sub-group of people involved in clinical trials..."

[montyhedge] 10/12/2020 18:46

I can't see the US approving Astra vaccine, until more data.

[beckers2008] 10/12/2020 17:31

G,

Morgan Stanley are confident in 19% per year for 5 years.
For 15% increase in EPS for each of the 5 years after FY 2021, EPS will be 766 giving a PE of circa 11 at £90 a share.

[gary1966] 10/12/2020 14:33

So at 15% profits will be double 2020 levels and 2.5 times at 20% in five years time. Impressive.

[beckers2008] 10/12/2020 13:23

P,

Conservative from Jefferies, if it wasn't for AZ trying to help the world at cost for the vaccine, AZN would be at least £90 per share.
Come 1st Jan, consensus forecasts show AZN will be on a forward PE of 21.3 for 2021 and yielding 2.6% covered 1.5 times.
Analysts are forecasting 15 to 20% growth in earnings per year for the next 5 years.

[philanderer] 10/12/2020 11:38

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,500 (8,100) PENCE - 'HOLD'

[philanderer] 10/12/2020 11:23

India Is Reportedly Seeking More Data On Oxford-AstraZeneca Vaccine Before Granting Emergency Authorization

[ayl30] 10/12/2020 07:36

https://www.nytimes.com/2020/12/08/business/covid-vaccine-oxford-astrazeneca.html

[philanderer] 10/12/2020 00:24

Covid vaccines: US regulator sceptical over AstraZeneca model

Vaccine developed in Oxford criticised by FDA with efficacy rates and trials delaying official take-up

[bartyb] 09/12/2020 08:45

Yes needs US trial with 30000

[bountyhunter] 09/12/2020 07:42

Oxford Covid vaccine 'safe and effective' study shows



Thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext

[thewheeliedealer] 08/12/2020 21:15

Hi all,

My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes AZN which we both hold and in particular I cover the Charting aspects. We also chatted about loads of other Stocks and Ideas for research. We discussed the outlook for Markets and the most likely roadmap for the next couple of months, and as usual a fair bit of educational stuff with regards to Investing.

Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 37) and you can find it on Soundcloud at the link below. It is also now on Youtube.

I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted.

Cheers, WD
@wheeliedealer

[philanderer] 08/12/2020 18:14

Evening G, more luck than judgement ;-)


"Oxford Covid vaccine 'safe and effective' study shows"

The Oxford/AstraZeneca Covid vaccine is safe and effective, giving good protection, researchers have confirmed in The Lancet journal.

Most in the study were younger than 55, but the results so far indicate it does work well in older people too.

The data also suggest it can reduce spread of Covid, as well as protect against illness and death.

The paper, assessed by independent scientists, sets out full results from advanced trials of over 20,000 people.

Regulators, who will have seen the same data, are considering the jab for emergency use.

But there are still important questions about what dose to give, as well as who it will protect.

When the interim trial results were made public in a press release about a fortnight ago, the researchers reported three efficacy levels for the vaccine - an overall effectiveness of 70%, a lower one of 62% and a high of 90%.

That's because different doses of the vaccine were used in one part of the trial. Some volunteers were given shots that were half the strength than originally planned.

Yet that "wrong" dose turned out to be a winner - giving 90% protection - while two standard doses gave 62%.